Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C. Ford, Damien Hindmarch, Matthew J Ridd et al.|The Lancet|2023Cited by 138
Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physiciansMałgorzata Krajnik, Sabina Panfilak, Nilay Hepgul et al.|BMC Pulmonary Medicine|2022Cited by 15